CAI
Caris Life Sciences, Inc.
27.50$
-9.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.8% | -0.7% | +56.6% | +26.9% | +14.9% | -9.3% | +64.0% | +55.4% | +45.6% | +20.7% | +7.2% | +10.6% | +3.5% | +18.2% | +24.0% | -3.7% | -10.0% | -72.5% | -42.4% | -16.8% | +227.5% | |
| – | +65.6% | +648.3% | +43.8% | -10.2% | +51.6% | -21.7% | +8.3% | +9.1% | +27.0% | +37.7% | +10.6% | -0.5% | -6.2% | +3.8% | +56.8% | +126.9% | -57.0% | +140.4% | -53.0% | -11.1% | +362.5% | |
| – | +65.6% | +36.9% | +168.8% | -58.6% | +238.4% | -49.2% | -0.7% | -2.2% | +25.5% | +158.8% | +17.7% | -2.4% | -12.2% | -23.2% | +27.9% | +2.5% | +15.2% | +100.2% | -47.4% | +13.4% | +1,147.5% | |
| – | +65.6% | +36.9% | +168.8% | -58.6% | +238.4% | -25.5% | -13.8% | +10.3% | +39.8% | +107.6% | +22.5% | +2.4% | -10.3% | -0.9% | +85.2% | -61.7% | +185.3% | +209.1% | -70.3% | -45.6% | +1,109.5% | |
| – | – | – | +16.2% | +10.4% | +16.1% | -18.4% | +21.0% | +12.5% | +37.3% | +4.0% | +17.4% | +0.4% | +9.5% | +20.3% | +70.8% | -7.1% | -9.6% | -72.1% | +37.5% | +59.6% | +27.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4.3% | -19.2% | +60.8% | |
| – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | +443.7% | +0.0% | +0.0% | +0.0% | – | – | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | -15.5% | +10.2% | -23.0% | -29.3% | -35.1% | -38.2% | -53.0% | -59.7% | +348.0% | +692.4% | -20.3% | -25.8% | -28.1% | – | – | – | – | – | |
| – | -11.1% | -6.6% | +72.9% | -10.7% | +31.1% | -18.0% | +69.7% | +69.5% | +47.8% | +21.1% | +7.3% | +12.7% | +4.8% | +16.8% | +23.8% | -4.5% | -13.5% | +26.7% | +5.7% | +11.1% | -80.7% | |
| – | – | – | +72.5% | -27.0% | -20.1% | -15.0% | +300.9% | -48.7% | +35.1% | +47.0% | +58.8% | -12.6% | -24.7% | +58.5% | +63.7% | -32.5% | +11.4% | -57.3% | -30.5% | +73.9% | -23.1% | |
| – | – | – | +685.9% | -99.4% | +14,461.3% | +2.2% | +533.8% | +1.1% | +114.1% | +20.1% | +168.7% | -15.6% | -44.6% | +38.2% | +135.8% | -30.0% | -15.9% | -68.9% | -88.2% | +879.7% | -99.7% | |
| – | – | – | +1.2% | -14.6% | +53.0% | +71.5% | -70.0% | +46.7% | +69.3% | +33.7% | +5.1% | +42.2% | +15.4% | -43.3% | -5.9% | -1.1% | -49.7% | +643.8% | -2.2% | +4.2% | +41.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.0% | +92.2% | +18.6% | |
| – | +57.0% | +38.5% | -15.9% | +372.5% | -13.2% | +13.5% | +39.1% | +28.1% | +50.8% | +19.5% | +6.7% | +4.1% | -0.6% | +23.2% | +24.3% | -1.1% | +1.3% | -342.4% | – | – | – | |
| – | – | – | -13.5% | +51.7% | -67.3% | +103.4% | +106.5% | +91.2% | +60.3% | +37.9% | +25.9% | +9.2% | +1.5% | +22.5% | +18.5% | +4.7% | +2.0% | -433.5% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -21.2% | +4.3% | +2.8% | +1.7% | +8.2% | +1.3% | +13.7% | -6.7% | -0.8% | -7.6% | +1.1% | +1.1% | -9.1% | -0.3% | +1,319.5% | 0.0% | +0.0% | +13.8% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.